Magna International Inc. Common Stock vs 22nd Century Group Inc — how do they compare? Magna International Inc. Common Stock trades at $63.96 (market cap $17.04B), while 22nd Century Group Inc trades at $0.8 (market cap $621.67K). The key difference: Magna International Inc. Common Stock is far larger — about 27410× 22nd Century Group Inc's market cap, and Magna International Inc. Common Stock pays a 3.1% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Magna International Inc. Common Stock for 1 Days and 22nd Century Group Inc for 32 Days on average.
| MGA | XXII | |
|---|---|---|
Market Cap | $17.04B | $621.67K |
Volume | 1,523,784 | 45,625 |
Sector | Consumer Cyclical | Consumer Staples |
52-Week High | $73.05 | $483.00 |
52-Week Low | $43.54 | $0.80 |
Typical Hold Time | 1 Days | 32 Days |
Enterprise Value | $22.08B | -$3.69M |
Dividend Yield | 3.1% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XXII trades at $0.8116, down 8.96% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.08 and P/B of 0.03. Recent news highlights regulatory progress in reduced-nicotine tobacco initiatives in France and Europe.
While analyst consensus is 75% buy with a $1,240 price target suggesting significant upside, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces execution risk in commercializing its reduced-nicotine platform amid ongoing losses.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Magna International Inc. is a Canada-based automotive supplier that designs, engineers, and manufactures vehicle systems and components, including body and chassis structures, seating, powertrain, and electronics, and provides complete-vehicle engineering and contract assembly, with manufacturing operations in 28 countries.
Read more on MGA →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →